The DOI matches its Crossref record.
ECPPA: randomised trial of low dose aspirin for the prevention of maternal and fetal complications in high risk pregnant women
Abstract
Objective To determine the effectiveness of low dose aspirin in women at high risk of adverse outcomes associated with pre‐eclampsia. Design A collaborative randomised trial comparing the effects of low dose aspirin (60 mg) with placebo on pre‐eclampsia and other materno‐fetal complications associated with hypertension. Setting Twelve teaching maternity hospitals and 182 obstetricians' offices in Brazil. Subjects One thousand and nine women considered to be at high risk for the development of pre‐eclampsia, or its complications, entered the study between 12 and 32 weeks of gestation. They were randomly allocated to receive aspirin (498 women) or placebo (511 women) until delivery, and follow up was obtained for 96%. Results There were no significant differences between the treatment groups in the incidence of proteinuric pre‐eclampsia (6.7% aspirin‐allocated compared with 6–0% placebo‐allocated women), of preterm delivery (22.3% compared with 26.1%), of intrauterine growth retardation (8.5% compared with 10.1%), or of stillbirth and neonatal death (7.3% compared with 6.0%), nor were there significant differences in the incidence of proteinuric pre‐eclampsia in any subgroup of women studied, including those who had systolic blood pressures of 120 mmHg or above at entry (8.5% compared with 7.3%) or those who were chronically hypertensive (10.0% compared with 7.1%). Aspirin was not associated with a significant excess of maternal or fetal bleeding. Conclusion The results of this study do not support the routine prophylactic administration of low dose aspirin in pregnancy to any category of high risk women (even those who have chronic hypertension or who are considered to be especially liable to early onset pre‐eclampsia).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
(2000) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2000.107928 · Cited by 3,270
Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems
Hofmeyr, G. J., Lawrie, T. A., Atallah, Á. N., & Duley, L. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001059.pub3 · Cited by 1,062
Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data
Askie, L. M., Duley, L., Henderson-Smart, D. J., & Stewart, L. A. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60712-0 · Cited by 1,020
Antiplatelet agents for preventing pre-eclampsia and its complications
Duley, L., Henderson-Smart, D. J., Meher, S., & King, J. F. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004659.pub2 · Cited by 1,016
Patrono, C., Coller, B., Dalen, J. E., Fitz Gerald, G. A., Fuster, V., Gent, M., Hirsh, J., & Roth, G. (2001) · Chest · doi:10.1378/chest.119.1_suppl.39s · Cited by 963
Metadata
- Authors
- ECPPA (Estudo Colaborativo para PrevenGdo da PrP‐eclampsia com Aspirina) Collaborative Group
- Venue
- BJOG: An International Journal of Obstetrics & Gynaecology
- Publisher
- Wiley
- Published
- 1996-01
- Volume
- 103
- Issue
- 1
- Pages
- 39-47
- ISSN
- 0306-5456 (ISSN-L)
- 1470-0328
- 1471-0528
- OpenAlex
- W2982836077
- Cited by
- 161
- References
- 0
- FWCI
- 23.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: ECPPA: randomised trial of low dose aspirin for the prevention of maternal and fetal complications in high risk pregnant women. https://app.cochat.ai/papers/10.1111/j.1471-0528.1996.tb09513.x
- The paper
- ECPPA (Estudo Colaborativo para PrevenGdo da PrP‐eclampsia com Aspirina) Collaborative Group. (1996). ECPPA: randomised trial of low dose aspirin for the prevention of maternal and fetal complications in high risk pregnant women. BJOG: An International Journal of Obstetrics & Gynaecology. https://doi.org/10.1111/j.1471-0528.1996.tb09513.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.